🖼

Fig. 3 — ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-df10b263ad52-3
Fig. 3 — ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
Fig. 3Figure 3
Lifestyle changes can influence the pathogenesis of AD. ApoE4 has been shown to increase Aβ and tau aggregation, inflammation, and lipid dysregulation while reducing glucose metabolism, microbiome diversity, and BBB integrity. Healthy lifestyle changes have been suggested to benefit cognitive function and ameliorate AD pathology even in the presence of APOE4 . Studies have demonstrated that ketogenic and Mediterranean diets as well as dietary supplements such as DHA can improve clinical outcomes. Along with diet, exercise has been shown to improve AD prognosis in apoE4 carriers. Chronic sleep disturbance appears to accelerate Aβ and tau pathology and exacerbate cognitive symptoms. The influence of APOE4 on sleep quality may lead to sleep disturbances in people at increased risk for dementia. Thus, improving sleep quality could reduce AD pathology and attenuate the negative impact of APOE4 on AD risk. The communication between gut microbiome and the brain, the microbiota-gut-brain
PubMed: paper-df10b263ad52
Metadata
pmidpaper-df10b263ad52
captionLifestyle changes can influence the pathogenesis of AD. ApoE4 has been shown to increase Aβ and tau aggregation, inflammation, and lipid dysregulation while reducing glucose metabolism, microbiome div
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC9644639/bin/13024_2022_574_Fig3_HTML.jpg
paper_titleApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
figure_labelFig. 3
figure_number3
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.